Parth Antibiotics Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 15 Year, 3 Months
- Last Filing with ROC 31 Mar 2020
- Revenue Growth 64.43%
- Profit Growth 92.98%
- Ebitda 196.88%
- Net Worth 28.84%
- Total Assets 39.70%
About Parth Antibiotics
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U51397MH2009PTC197201
- Company No.
197201
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Nov 2009
- Date of AGM
28 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Parth Antibiotics?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Devang Ajmera  | Director | 21-Nov-2009 | Current |
| Piyush Ajmera | Director | 21-Nov-2009 | Current |
| Bhavin Ajmera | Director | 21-Nov-2009 | Current |
Financial Performance of Parth Antibiotics.
Parth Antibiotics Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 64.43% increase. The company also saw a substantial improvement in profitability, with a 92.98% increase in profit. The company's net worth Soared by an impressive increase of 28.84%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Parth Antibiotics?
In 2019, Parth Antibiotics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Dpb Pharmaceuticals LimitedDevang Ajmera, Piyush Ajmera and 1 more are mutual person
Vardhman Chemtech LimitedDevang Ajmera, Piyush Ajmera and 1 more are mutual person
Kinvan Private LimitedDevang Ajmera is a mutual person
- Dpb Antibiotics Private Limited
Devang Ajmera, Piyush Ajmera and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Parth Antibiotics?
Unlock and access historical data on people associated with Parth Antibiotics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Parth Antibiotics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Parth Antibiotics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.